Autoantibodies and liver disease: Uses and abuses

Canadian Journal of Gastroenterology

Volumn 24, Issue 4, 2010, Pages 225-231

  Zeman, Marilyn V ^a,b   Hirschfield, Gideon M ^a,b  

^a TORONTO WESTERN HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Autoantibodies; Autoimmune hepatitis; Autoimmune liver disease; Primary biliary cirrhosis; Sclerosing cholangitis

Indexed keywords

ACTIN; ANTINUCLEAR ANTIBODY; AUTOANTIBODY; HISTONE; MICROSOME ANTIBODY; MITOCHONDRION ANTIBODY; SMOOTH MUSCLE ANTIBODY;

AUTOIMMUNE HEPATITIS; BLOOD ANALYSIS; CELIAC DISEASE; CHRONIC HEPATITIS; CHRONIC LIVER DISEASE; CLINICAL EVALUATION; CLINICAL FEATURE; CLINICAL RESEARCH; CYTOSOL; DISEASE CLASSIFICATION; HEPATITIS C; HUMAN; LABORATORY TEST; LIVER BIOPSY; LIVER GRAFT; MEDICAL PRACTICE; METABOLIC DISORDER; PRIORITY JOURNAL; REVIEW; SCLEROSING CHOLANGITIS; SEROLOGY; VIRUS INFECTION;

EID: 77951793900     PISSN: 08357900     EISSN: None     Source Type: Journal    
DOI: 10.1155/2010/431913     Document Type: Review

References (34)

1. Strassburg CP, Manns MP. Autoantibodies and autoantigens in autoimmune hepatitis. Semin Liver Dis 2002;22:339-352
2. Manns MP, Vogel A. Autoimmune hepatitis, from mechanisms to therapy. Hepatology 2006;43:S132-44.
3. Czaja AJ, Freese DK. Diagnosis and treatment of autoimmune hepatitis. Hepatology 2002;36:479-497
4. Heathcote EJ. Management of primary biliary cirrhosis. The American Association for the Study of Liver Diseases practice guidelines. Hepatology 2000;31:1005-1013
5. LaRusso NF, Shneider BL, Black D, et al. Primary sclerosing cholangitis: Summary of a workshop. Hepatology 2006;44:746-764 (Pubitemid 44433732)
6. Montano-Loza AJ, Lalor E, Mason AL. Recognizing immunoglobulin G4-related overlap syndromes in patients with pancreatic and hepatobiliary diseases. Can J Gastroenterol 2008;22:840-846
7. Elkon K, Casali P. Nature and functions of autoantibodies. Nat Clin Pract Rheumatol 2008;4:491-498
8. Mackay IR. Historical reflections on autoimmune hepatitis. World J Gastroenterol 2008;14:3292-3300
9. Keren DF. Antinuclear antibody testing. Clin Lab Med 2002;22:447-474
10. Vergani D, Alvarez F, Bianchi FB, et al. Liver autoimmune serology: A consensus statement from the committee for autoimmune serology of the International Autoimmune Hepatitis Group. J Hepatol 2004;41:677-683 (Pubitemid 39297806)
11. Muratori L, Granito A, Muratori P, et al. Antimitochondrial antibodies and other antibodies in primary biliary cirrhosis: Diagnostic and prognostic value. Clin Liver Dis 2008;12:261-276 (Pubitemid 351635893)
12. Frenzel C, Herkel J, Luth S, et al. Evaluation of F-actin ELISA for the diagnosis of autoimmune hepatitis. Am J Gastroenterol 2006;101:2731-2736 (Pubitemid 44902644)
13. Bogdanos DP, Invernizzi P, Mackay IR, Vergani D. Autoimmune liver serology: Current diagnostic and clinical challenges. World J Gastroenterol 2008;14:3374-3387
14. Philipp T, Durazzo M, Trautwein C, et al. Recognition of uridine diphosphate glucuronosyl transferases by LKM-3 antibodies in chronic hepatitis D. Lancet 1994;344:578-581 (Pubitemid 124002923)
15. Leung PS, Rossaro L, Davis PA, et al. Antimitochondrial antibodies in acute liver failure: Implications for primary biliary cirrhosis. Hepatology 2007;46:1436-1442 (Pubitemid 350155525)
16. Bhat M, Guindi M, Heathcote EJ, Hirschfield GM. Transient development of anti-mitochondrial antibodies accompanies autoimmune hepatitis-sclerosing cholangitis overlap. Gut 2009;58:152-153
17. Wijeyesinghe U, Russell AS. Outcome of high titer antinuclear antibody positivity in individuals without connective tissue disease: A 10-year follow-up. Clin Rheumatol 2008;27:1399-1402
18. Kavanaugh A, Tomar R, Reveille J, et al. Guidelines for clinical use of the antinuclear antibody test and tests for specific autoantibodies to nuclear antigens. American College of Pathologists. Arch Pathol Lab Med 2000;124:71-81. (Pubitemid 30053777)
19. Alvarez F, Berg PA, Bianchi FB, et al. International Autoimmune Hepatitis Group Report: Review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999;31:929-938 (Pubitemid 29514229)
20. Hennes EM, Zeniya M, Czaja AJ, et al. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology 2008;48:169-176 (Pubitemid 351975541)
21. Cassani F, Cataleta M, Valentini P, et al. Serum autoantibodies in chronic hepatitis C: Comparison with autoimmune hepatitis and impact on the disease profile. Hepatology 1997;26:561-566 (Pubitemid 27392344)
22. Holdener M, Hintermann E, Bayer M, et al. Breaking tolerance to the natural human liver autoantigen cytochrome P450 2D6 by virus infection. J Exp Med 2008;205:1409-1422 (Pubitemid 351831496)
23. O'Brien C, Joshi S, Feld JJ, et al. Long-term follow-up of antimitochondrial antibody-positive autoimmune hepatitis. Hepatology 2008;48:550-556
24. Kaplan MM, Gershwin ME. Primary biliary cirrhosis. N Engl J Med 2005;353:1261-1273
25. Oertelt S, Rieger R, Selmi C, et al. A sensitive bead assay for antimitochondrial antibodies: Chipping away at AMA-negative primary biliary cirrhosis. Hepatology 2007;45:659-665 (Pubitemid 46450617)
26. Zein CO, Angulo P, Lindor KD. When is liver biopsy needed in the diagnosis of primary biliary cirrhosis? Clin Gastroenterol Hepatol 2003;1:89-95.
27. Nakamura M, Kondo H, Mori T, et al. Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis. Hepatology 2007;45:118-127 (Pubitemid 46144371)
28. Hov JR, Boberg KM, Karlsen TH. Autoantibodies in primary sclerosing cholangitis. World J Gastroenterol 2008;14:3781-3791
29. Das KM. Immunopathogenesis of primary sclerosing cholangitis: Possible role of a shared colonic and biliary epithelial antigen. J Gastrol Hepatol 2004;19:S290-4.
30. Sakamaki S, Takayanagi N, Yoshizaki N, et al. Autoantibodies against the specific epitope of human tropomyosin(s) detected by a peptide based enzyme immunoassay in sera of patients with ulcerative colitis show antibody dependent cell mediated cytotoxicity against HLA-DPw9 transfected L cells. Gut 2000;47:236-241 (Pubitemid 30489767)
31. Xu B, Broome U, Ericzon BG, Sumitran-Holgersson S. High frequency of autoantibodies in patients with primary sclerosing cholangitis that bind biliary epithelial cells and induce expression of CD44 and production of interleukin 6. Gut 2002;51:120-127 (Pubitemid 34717756)
32. Rigopoulou EI, Mytilinaiou M, Romanidou O, et al. Autoimmune hepatitis-specific antibodies against soluble liver antigen and liver cytosol type 1 in patients with chronic viral hepatitis. J Autoimmune Dis 2007;4:2.
33. Fritzler MJ. Challenges to the use of autoantibodies as predictors of disease onset, diagnosis and outcomes. Autoimmun Rev 2008;7:616-620
34. Tahiri F, Le Naour F, Huguet S, et al. Identification of plasma membrane autoantigens in autoimmune hepatitis type 1 using a proteomics tool. Hepatology 2008;47:937-948 (Pubitemid 351449685)